Aimei Health Technology AFJK
NASDAQ AFJK
$12.56 +0.23 (+1.87%)
As of: Aug 21, 2026 · 3:59 PM EDT

Aimei Health Technology (AFJK) Cash from Financing Activities (2025)

Aimei Health Technology (AFJK) posted quarterly Cash from Financing Activities of $546950.0 for Q3 2025, down 15.4% quarter-over-quarter from $646543.0 in Q2 2025.

Aimei Health Technology (AFJK) Cash from Financing Activities (2025) Analysis & Trends

Aimei Health Technology (AFJK) has reported Cash from Financing Activities for 1 consecutive years, with $546950.0 the latest figure, recorded in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - -
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - -
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - -
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -
6 Aldel Financial 397.49 Mn 397.49 Mn - -
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - -
8 Gores Holdings X 385.06 Mn 384.87 Mn - -
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -
10 Aimei Health Technology 50.90 Mn 50.89 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 546,950.00
Sep 30, 2025 546,950.00
Jun 30, 2025 646,543.00
Jun 30, 2025 646,543.00
Mar 31, 2025 -30.58 Mn
Mar 31, 2025 -30.58 Mn